REGULATORY

Chuikyo Healthcare, Payer Reps Still Divided Over Off-Year Re-Pricing Debate

November 19, 2020

- Only subscribers can save articles.
  
  Sign In
  
  Subscribe

Members of an all-important reimbursement policy panel on November 18 remained at odds over how they should proceed with discussions on the government’s planned “off-year” re-pricing scheduled for next April. Healthcare providers want price survey results to be carefully vetted…

To read the full story

Chuikyo Reps Raise No Opposition to Off-Year Re-Pricing, Still Split over Product Scope
December 3, 2020

REGULATORY

MHLW to Allow OTC Drugs to Match Prescription Doses under Specific Conditions
February 5, 2026
Japan Launches Biotechnology Working Group, Roadmap Draft Due in April
February 4, 2026
Japan Panel Backs Nonprescription Switch of Second Emergency Contraceptive
February 4, 2026
MHLW Set to Launch Searchable Drug Supply Database in April
February 3, 2026
MHLW Pushes Back GCP Ordinance Revision to Summer
February 3, 2026

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo OKs New CEA Handling, with Third-Party Verification Ahead

Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…

COMMENTARY

TSE’s Growth Market Reform Puts Pressure on Biotechs

By Tatsuya Otsuka

Japan’s biotech startups are coming under growing pressure as the Tokyo Stock Exchange (TSE) tightens its rules for companies listed…

COLUMN

AI in Healthcare Hiring: Leveling the Playing Field & Unlocking Human Potential

By Philip Carrigan

The Japanese healthcare sector is experiencing rapid growth, demanding a highly skilled and diverse workforce. However, finding and attracting the best talent in this competitive market presents significant challenges.Enter AI. With the rise of AI-powered tools, healthcare organizations can revolutionize…